Welcome to LookChem.com Sign In|Join Free
  • or
Ethylmethylglycinexylidide is a chemical compound that functions as a local anesthetic and an antiarrhythmic agent. It is a derivative of lidocaine and is classified within the amide local anesthetics. ethylmethylglycinexylidide shares a similar structure and function to lidocaine but possesses distinct properties that render it advantageous for specific medical applications. It is frequently utilized as a test drug to gauge individual reactions to other amide local anesthetics and to evaluate liver function. Beyond its anesthetic capabilities, ethylmethylglycinexylidide has been studied for its potential in managing ventricular arrhythmias and atrial fibrillation.

74634-66-5

Post Buying Request

74634-66-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

74634-66-5 Usage

Uses

Used in Medical Applications:
Ethylmethylglycinexylidide serves as a local anesthetic, providing pain relief during medical procedures. It is used as an anesthetic agent for [application reason], offering a temporary loss of sensation in a specific area of the body.
Used in Cardiology:
In the field of cardiology, ethylmethylglycinexylidide is used as an antiarrhythmic agent for [application reason], helping to regulate abnormal heart rhythms and prevent complications associated with arrhythmias.
Used in Predictive Medicine:
Ethylmethylglycinexylidide is utilized as a test drug for [application reason], allowing healthcare professionals to predict individual responses to other amide local anesthetics and assess liver function, which is crucial for personalized treatment plans and medication management.
Used in Research:
ethylmethylglycinexylidide is also used in research settings for [application reason], as it provides insights into the development of new treatments for ventricular arrhythmias and atrial fibrillation, contributing to advancements in cardiovascular medicine.

Check Digit Verification of cas no

The CAS Registry Mumber 74634-66-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,6,3 and 4 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 74634-66:
(7*7)+(6*4)+(5*6)+(4*3)+(3*4)+(2*6)+(1*6)=145
145 % 10 = 5
So 74634-66-5 is a valid CAS Registry Number.
InChI:InChI=1/C13H20N2O/c1-5-15(4)9-12(16)14-13-10(2)7-6-8-11(13)3/h6-8H,5,9H2,1-4H3,(H,14,16)

74634-66-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(2,6-dimethylphenyl)-2-[ethyl(methyl)amino]acetamide

1.2 Other means of identification

Product number -
Other names Ethylmethylglycinexylidide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:74634-66-5 SDS

74634-66-5Upstream product

74634-66-5Downstream Products

74634-66-5Relevant academic research and scientific papers

SUBSTITUTED ACETANILIDES AND BENZAMIDES FOR THE TREATMENT OF ASTHMA AND PULMONARY INFLAMMATION

-

Page/Page column 42, (2008/06/13)

Substituted acetanilide or benzamide compositions or formulations for delivery by aerosolization are described. The formulation contains an efficacious amount of acetanilide or benzamide compound able to inhibit inflammation in asthmatic lungs. Compounds of the invention are formulated in 5 ml solution of a quarter normal saline having pH between 5.0 and 7.0. The method for treatment of respiratory tract inflammation by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5 μ, produced by nebulization or dry powder inhaler.

Cyclizing compounds. 3. Local anesthetic action of N (ω haloalkyl) N methylaminoaceto 2,6 xylidides

Ross,Sandberg,Akerman,Domeij,Stening,Svensson

, p. 787 - 790 (2007/10/06)

A series of N (ω chloroalkyl) N methylaminoaceto 2,6 xylidides which are able to cyclize to quaternary ammonium derivates was synthesized and examined for local anesthetic action. As reference compounds the corresponding series of N alkylamine derivates were synthesized and tested. In both series of compounds the duration of anesthesia was prolonged by increasing the size of the side chain. In the N alkylamine series an optimal effect was obtained for the N hexylamine derivate. The duration of anesthesia produced by the cyclizing compounds in the sciatic nerve test in vivo was somewhat shorter than that for the noncyclizing compounds. The observation that the N 4 chlorobutyl derivate produced a longer block than the 5 chloropentylamine in this test indicates that the quaternary compounds formed may contribute to the duration of anesthesia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 74634-66-5